Datasea Announces Foundational Research Breakthrough in Ultrasonic-Enhanced Nanoscale Precision Control
Establishing an Engineering-Level Core Technology for Next-Generation Semiconductor Manufacturing Applications BEIJING, Feb. 18, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company specializing in acoustic high-tech solutions and 5G+AI multimodal digitalization, today announced that it has achieved a foundational research breakthrough in its ultrasonic-enhanced nanoscale...
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the China National Medical Products Administration (NMPA) has approved...
DXC Technology’s AI Impact Helps Customers Across Industries Innovate with AI
AI Impact leverages DXC's combined consulting, engineering, and secure enterprise services ASHBURN, Va., Jan. 6, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced AI Impact, an approach designed to help solve customers' most pressing challenges. By combining DXC consulting, engineering and secure enterprise services, DXC will help clients across industries securely innovate and...
Starpharma presents compelling data in Prostate Cancer at ESMO
MELBOURNE, Australia, Sept. 13, 2022 /PRNewswire/ -- Cabazitaxel (Jevtana, Sanofi) is a market leading chemotherapy for the treatment of advanced prostate cancer (mCRPC). Developed by Australian biotech company Starpharma, DEP® cabazitaxel is a patented, highly water soluble dendrimer nanoparticle version of standard cabazitaxel which has shown, in preclinical and clinical studies, benefits in terms of safety and efficacy. Positive...
Data4Life releases Data2Evidence as open source: a new chapter for global health research
POTSDAM, Germany, April 2, 2025 /PRNewswire/ -- Data4Life, the nonprofit digital health organization, today announced the open-source release of its research platform Data2Evidence (D2E). With this move, Data4Life is equipping researchers and developers worldwide with powerful tools to integrate, manage, and analyze heterogeneous health data. By adopting an open-source strategy, the organization aims to foster scientific collaboration, accelerate innovation,...
Jenscare Announces 2025H1 Interim Results
BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases, achieved key milestones in its product portfolio and just announced its interim results for 2025H1. Business Highlights: Big Movement in Commercialization, Registration and Clinical LuX-Valve Series, TTVR system...
uLab™ clear aligner platform is now available in Australia and New Zealand
MEMPHIS, Tenn., July 22, 2022 /PRNewswire/ -- uLab Systems™, the creator of the uSmile™ clear aligner system and the uDesign® treatment planning software, announces the clearance of the uLab product suite from the Therapeutic Goods Administration (TGA) and Medsafe, the regulatory authorities for therapeutic goods in Australia and New Zealand respectively....
Ando Foundation and Nissin Food Products Release “Recipes for Wellbeing Report”: First Global Study Reveals Direct Correlation Between Food and Wellbeing
OSAKA, Japan, Oct. 18, 2023 /PRNewswire/ -- The Ando Foundation (*) (hereinafter "the Foundation") and Nissin Food Products Co., Ltd. (hereinafter "the Company") released the Recipes for Wellbeing Report on October 18, 2023, in cooperation with global analytics and advice firm Gallup, the first global study offering a fresh perspective on the food-wellbeing connection. (*) The Foundation was established...
TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS
Jaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer and Rachel Mooney, Chief Communications Officer BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on a disruptive proprietary technology platform, today announced the appointment of three new members to...
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
MELBOURNE, Australia, Feb. 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides...
